Log in to save to my catalogue

TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer

TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2c544d649b024c5bbd721b91d7f7c740

TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer

About this item

Full title

TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer

Publisher

United States: John Wiley & Sons, Inc

Journal title

Cancer medicine (Malden, MA), 2021-12, Vol.10 (23), p.8581-8594

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
Whereas the genomic landscape of endocrine‐resistant breast cancer has been intensely characterized in previously treated cases with local or distant recurrence, comparably little is known about genomic alterations conveying primary non‐responsiveness to endocrine treatment in luminal early breast cancer.
Methods
In this study,...

Alternative Titles

Full title

TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2c544d649b024c5bbd721b91d7f7c740

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2c544d649b024c5bbd721b91d7f7c740

Other Identifiers

ISSN

2045-7634

E-ISSN

2045-7634

DOI

10.1002/cam4.4376

How to access this item